153 related articles for article (PubMed ID: 24775638)
1. Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.
Yang H; He X; Zheng Y; Feng W; Xia X; Yu X; Lin Z
Chem Biol Drug Des; 2014 Nov; 84(5):578-84. PubMed ID: 24775638
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells.
Yu Q; Wang X; Wang L; Zheng J; Wang J; Wang B
Scand J Gastroenterol; 2016 Oct; 51(10):1220-6. PubMed ID: 27251594
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells.
Li H; Zhou F; Du W; Dou J; Xu Y; Gao W; Chen G; Zuo X; Sun L; Zhang X; Yang S
Biotechnol Appl Biochem; 2016 May; 63(3):328-33. PubMed ID: 25858017
[TBL] [Abstract][Full Text] [Related]
4. Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase.
Xu Y; Lv F; Zhu X; Wu Y; Shen X
Cancer Gene Ther; 2016 Sep; 23(9):287-94. PubMed ID: 27444726
[TBL] [Abstract][Full Text] [Related]
5. Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
Nishikawa G; Kawada K; Hanada K; Maekawa H; Itatani Y; Miyoshi H; Taketo MM; Obama K
Cells; 2022 Oct; 11(20):. PubMed ID: 36291140
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.
Yang M; Gao H; Chen P; Jia J; Wu S
Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells.
Wang Y; Jin T; Dai X; Xu J
Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787
[TBL] [Abstract][Full Text] [Related]
8. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY
Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751
[TBL] [Abstract][Full Text] [Related]
9. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin.
Cui H; Darmanin S; Natsuisaka M; Kondo T; Asaka M; Shindoh M; Higashino F; Hamuro J; Okada F; Kobayashi M; Nakagawa K; Koide H; Kobayashi M
Cancer Res; 2007 Apr; 67(7):3345-55. PubMed ID: 17409444
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells.
Han J; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Wu B; Wang Y; Niu R
Cancer Lett; 2012 Aug; 321(1):80-8. PubMed ID: 22381696
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitro.
Lwin ZM; Yip GW; Chew FT; Bay BH
Anat Rec (Hoboken); 2012 Mar; 295(3):410-6. PubMed ID: 22266712
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.
Wang L; Gao W; Hu F; Xu Z; Wang F
FEBS Lett; 2014 Dec; 588(24):4527-35. PubMed ID: 25281924
[TBL] [Abstract][Full Text] [Related]
14. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma.
Li Y; Zhang X; Hu T; Han L; Li R; Wen J; Zhang M
Oncol Rep; 2014 Aug; 32(2):853-9. PubMed ID: 24913732
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic tumor sensitivity to plasma L-asparagine starvation.
Dufour E; Gay F; Aguera K; Scoazec JY; Horand F; Lorenzi PL; Godfrin Y
Pancreas; 2012 Aug; 41(6):940-8. PubMed ID: 22513289
[TBL] [Abstract][Full Text] [Related]
16. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways.
Zheng B; Chai R; Yu X
Int J Mol Med; 2015 May; 35(5):1317-22. PubMed ID: 25738796
[TBL] [Abstract][Full Text] [Related]
18. Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.
Sircar K; Huang H; Hu L; Cogdell D; Dhillon J; Tzelepi V; Efstathiou E; Koumakpayi IH; Saad F; Luo D; Bismar TA; Aparicio A; Troncoso P; Navone N; Zhang W
Am J Pathol; 2012 Mar; 180(3):895-903. PubMed ID: 22245216
[TBL] [Abstract][Full Text] [Related]
19. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
20. p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival.
Deng L; Yao P; Li L; Ji F; Zhao S; Xu C; Lan X; Jiang P
Nat Commun; 2020 Apr; 11(1):1755. PubMed ID: 32273511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
